Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2015 09:32
Scientists have hailed the potential of the new drug
A new drug could help patients with a devastating form of lung cancer to live longer, it has been suggested.
Nivolumab, an immuno-therapy drug that unshackles the immune system so it can attack cancerous cells, has been shown to double the life expectancy of genetically targeted patients with advanced non-squamous non-small cell lung cancer.
One expert has described the results of the major international trial as a "paradigm shift" in the battle against lung cancer.
Lung cancer is one of the UK's most serious forms of the disease.
Advanced non-squamous non-small cell lung cancer accounts for around 85% of all cases of the lung disease, which is diagnosed in 43,463 new patients and is responsible for 35,371 deaths each year in the UK.
Overseas travel
Like other cancers, treatment depends on how far it has spread and how good your general health is.
But whether you are a cancer survivor or are undergoing treatment, cancer travel insurance means you can still enjoy jetting off to sunnier climes around the world with family and friends.
Policies can include cover for replacing lost medication and access to 24/7 emergency assistance.
Longer life expectancy
The new research, led by Dr Luis Paz-Ares, from the Hospital Universitario Virgen Del Rocio in Spain, compared the effectiveness of nivolumab and the standard chemotherapy drug docetaxel in 582 patients with advanced non-squamous non-small cell lung cancer.
Nivolumab reduced the risk of dying by 27% compared with docetaxel and increased typical survival time from 9.4 to 12.2 months.
In patients whose cancers produced higher levels of a tumour protein called PD-L1, survival time more than doubled from eight to 19.4 months.
Dr David Chao, consultant medical oncologist at the Royal Free Hospital in London, described the findings as a paradigm shift in the treatment of lung cancer.
14 July 2018
Too many passengers heading abroad this summer will be travelling without adequate protection for when an airline goes bust, a new study has shown.
[more...]
13 July 2018
The mother of Bradley Lowery has welcomed the news that a drug used to help treat her son will soon be made available for other patients on the NHS.
12 July 2018
British GPs have prevented thousands of strokes after learning how to better identify and treat a common heart condition, research has shown.
11 July 2018
London City Airport is considering lodging an application to increase flight and passenger numbers, its boss has revealed.
10 July 2018
Captain Harry Kane is leading England's unexpected bid for glory, and is hoping to inspire the next generation of footballers by going all the way in Russia.
07 July 2018
Experts have warned that a lack of rigorous testing of skin cancer detection apps is putting the public at risk.
06 July 2018
Easyjet has added to worries that travellers are set for a summer of chaos, revealing that nearly 1,300 flights were cancelled last month.
05 July 2018
Soaring temperatures across the UK have led to a surge of asthma sufferers calling a dedicated asthma helpline, a charity has revealed.
04 July 2018
Strikes across Europe led Ryanair to cancel over 1,000 flights in June, the budget airline has revealed.
03 July 2018
Sarcoma cancer is "more common than previously thought" with 15 people in the UK diagnosed with the illness every day, a charity has warned.
30 June 2018
The UK is set to scorch this weekend as the heatwave continues and temperatures stay well in the 30s.
29 June 2018
Passengers travelling to Heathrow this summer could continue to face lengthy queues, a top Home Office official has warned.